Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis.
Caroline AmandSabine TongAlexia KiefferMoe H KyawPublished in: BMC health services research (2018)
Our findings showed a substantial annual RSV-attributable healthcare resource use and costs in the US across age groups, with the highest burden in those aged ≥65 years. These data can be used in cost-effectiveness analyses, and may be useful for policymakers to guide future RSV vaccination and other prevention programs.